These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
553 related articles for article (PubMed ID: 9803586)
1. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana. Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586 [TBL] [Abstract][Full Text] [Related]
2. [Comparative serological efficacy of the measles vaccine strains Edmonston-Zagreb, Schwarz and AIK-C in Togolese infants of 4-5 months and 8-10 months]. Tidjani O; Grunitzky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K Bull Soc Pathol Exot; 1991; 84(5 Pt 5):873-84. PubMed ID: 1819435 [TBL] [Abstract][Full Text] [Related]
3. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines. Markowitz LE; Sepulveda J; Diaz-Ortega JL; Valdespino JL; Albrecht P; Zell ER; Stewart J; Zarate ML; Bernier RH N Engl J Med; 1990 Mar; 322(9):580-7. PubMed ID: 2304505 [TBL] [Abstract][Full Text] [Related]
4. Seroconversion after measles vaccination at nine and fifteen months of age. Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and safety of standard-titer AIK-C measles vaccine in nine-month-old infants. Tsai HY; Huang LM; Shih YT; Chen JM; Jiang TM; Tsai CH; Lee CY Viral Immunol; 1999; 12(4):343-8. PubMed ID: 10630793 [TBL] [Abstract][Full Text] [Related]
6. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era. Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581 [TBL] [Abstract][Full Text] [Related]
7. Trial of Edmonston-Zagreb measles vaccine in infants aged under nine months. Pongrithsukda V; Gluck R; Suwatanapongched S; Kaewmalung P; Muyakul J Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):347-50. PubMed ID: 1818384 [TBL] [Abstract][Full Text] [Related]
8. Serological effects of Edmonston-Zagreb, Schwarz, and AIK-C measles vaccine strains given at ages 4-5 or 8-10 months. Tidjani O; Grunitsky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K Lancet; 1989 Dec; 2(8676):1357-60. PubMed ID: 2574304 [TBL] [Abstract][Full Text] [Related]
9. Lack of efficacy of the standard potency Edmonston-Zagreb live, attenuated measles vaccine in African infants. Kiepiela P; Coovadia HM; Loening WE; Coward P; Botha G; Hugo J; Becker PJ Bull World Health Organ; 1991; 69(2):221-7. PubMed ID: 1860150 [TBL] [Abstract][Full Text] [Related]
10. Antibody response after measles immunization. Ariyasriwatana C; Kalayanarooj S; Pattamadilok S J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170 [TBL] [Abstract][Full Text] [Related]
11. Immunization of 6 and 9 month old infants with AIK-C, Edmonston-Zagreb, Leningrad-16 and Schwarz strains of measles vaccine. Bolotovski VM; Grabowsky M; Clements CJ; Albrecht P; Brenner ER; Zargaryantzs AI; Litvinov SK; Mikheyeva IV Int J Epidemiol; 1994 Oct; 23(5):1069-77. PubMed ID: 7860158 [TBL] [Abstract][Full Text] [Related]
12. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States. Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants. Gatchalian S; Yao Y; Zhou B; Zhang L; Yoksan S; Kelly K; Neuzil KM; Yaïch M; Jacobson J Vaccine; 2008 Apr; 26(18):2234-41. PubMed ID: 18394765 [TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children. Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL Vaccine; 2006 Jan; 24(5):683-90. PubMed ID: 16154241 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of measles antibodies before and after vaccination in previously unvaccinated children of the Cordillera Province (Santa Cruz Department, Bolivia). Guglielmetti P; Bianchi Bandinelli ML; Bartoloni A; Gamboa H; Roselli M; Valensin PE J Trop Med Hyg; 1994 Aug; 97(4):231-5. PubMed ID: 8064946 [TBL] [Abstract][Full Text] [Related]
16. Seroconversion rates and measles antibody titers induced by measles vaccination in Latin American children six to 12 months of age. Rev Infect Dis; 1983; 5(3):596-605. PubMed ID: 6879022 [TBL] [Abstract][Full Text] [Related]
17. Measles control in Maputo, Mozambique, using a single dose of Schwarz vaccine at age 9 months. Cutts FT; Monteiro O; Tabard P; Cliff J Bull World Health Organ; 1994; 72(2):227-31. PubMed ID: 8205642 [TBL] [Abstract][Full Text] [Related]
18. Follow-up of infants given measles vaccine at 6 months of age: antibody and CMI responses to MMRII at 15 months of age and antibody levels at 27 months of age. Carson MM; Spady DW; Beeler JA; Krezolek MP; Audet S; Pabst HF Vaccine; 2005 May; 23(25):3247-55. PubMed ID: 15837229 [TBL] [Abstract][Full Text] [Related]
19. Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses. Halsey NA; Boulos R; Mode F; Andre J; Bowman L; Yaeger RG; Toureau S; Rohde J; Boulos C N Engl J Med; 1985 Aug; 313(9):544-9. PubMed ID: 4022091 [TBL] [Abstract][Full Text] [Related]
20. Reduced seroconversion to measles in infants given vitamin A with measles vaccination. Semba RD; Munasir Z; Beeler J; Akib A; Muhilal ; Audet S; Sommer A Lancet; 1995 May; 345(8961):1330-2. PubMed ID: 7752754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]